Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 10Recruiting 3Terminated 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Margins of Excision 1Carcinoma, Basal Cell 1

Interventions

pembrolizumab 439Carboplatin 322Nivolumab 298Cyclophosphamide 286Specimen Handling 271Magnetic Resonance Spectroscopy 259Cisplatin 250Paclitaxel 249Radiotherapy 230Dexamethasone 184Biopsy 182Gemcitabine 180durvalumab 171atezolizumab 152Doxorubicin 141Rituximab 138Lenalidomide 136Ipilimumab 134Docetaxel 132Bevacizumab 132Radiation 121Capecitabine 120Oxaliplatin 116Etoposide 116Radiosurgery 113Fluorouracil 112Pemetrexed 109fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Microscopy, Confocal × Clear all
NCT05935995 2025-11-28

HISTOBLOC

Institut de Cancérologie de Lorraine

Phase NA Active not recruiting
42 enrolled
DermatologicHead & Neck

Margins of Excision, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡